.Pharmacolibrary.Drugs.ATC.N.N05CH01 .Pharmacolibrary.Drugs.ATC.N.N05CH01| name: | Melatonin |
| ATC code: | N05CH01 | route: | oral |
| n-compartments | 1 |
Melatonin is an endogenous hormone produced by the pineal gland involved in the regulation of circadian rhythms and sleep-wake cycles. As a drug, melatonin is primarily used to treat insomnia, jet lag, and circadian rhythm sleep disorders, and is available as an over-the-counter supplement in many countries. It is generally considered safe with limited adverse effects and is not approved as a prescription medication in most regions, but is widely used for sleep-related complaints.
Pharmacokinetic parameters following oral administration of 2 mg controlled-release melatonin in healthy adult volunteers (both sexes, age range 18–65 years).
Lalanne, S, et al., & Tordjman, S (2021). Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder. International journal of molecular sciences 22(3) –. DOI:10.3390/ijms22031490 PUBMED:https://pubmed.ncbi.nlm.nih.gov/33540815
Bienert, A, et al., & Grześkowiak, E (2015). Melatonin and clonidine premedication has similar impact on the pharmacokinetics and pharmacodynamics of propofol target controlled-infusions. Journal of clinical pharmacology 55(3) 307–316. DOI:10.1002/jcph.401 PUBMED:https://pubmed.ncbi.nlm.nih.gov/25243731
Li, Y, et al., & Zhang, J (2014). Bio-mimetic drug delivery systems designed to help the senior population reconstruct melatonin plasma profiles similar to those of the healthy younger population. Acta pharmaceutica Sinica. B 4(1) 60–66. DOI:10.1016/j.apsb.2013.12.006 PUBMED:https://pubmed.ncbi.nlm.nih.gov/26579365